Drug Search Results
More Filters [+]

Litenimod

Alternative Names: litenimod
Latest Update: 2024-11-16
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: N/A

Novel Mechanism: No

Modality: Large Molecule

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Assistance Publique Hopitaux de Paris
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Litenimod

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Glioblastoma

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

APHP240512

P2

Unknown Status

Glioblastoma

2027-02-28

Recent News Events

Date

Type

Title